Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
The Journal of Nutritional Biochemistry|December 19, 2024
Protective effects of Kaempferol on hepatic apoptosis via miR-26a-5p enhancement and regulation of TLR4/NF-κB and PKCδ in a rat model of nonalcoholic fatty liverEman H Basha, Islam Ibrahim Hegab, Radwa Ismail, et al.
Blood Advances|October 6, 2025
FLT3-ITD measurable residual disease from the QuANTUM-First trialMark J Levis, Harry P Erba, Pau Montesinos, et al.
Lancet (London, England)|April 28, 2023
Quizartinib plus chemotherapy in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): a randomised, double-blind, placebo-controlled, phase 3 trialHarry P Erba, Pau Montesinos, Hee-Je Kim, et al.
International Journal of Molecular Sciences|January 11, 2025
Adropin/Tirzepatide Combination Mitigates Cardiac Metabolic Aberrations in a Rat Model of Polycystic Ovarian Syndrome, Implicating the Role of the AKT/GSK3β/NF-κB/NLRP3 PathwayIslam Ibrahim Hegab, Hemat El-Sayed El-Horany, Rania Nagi Abd-Ellatif, et al.
BMC Pulmonary Medicine|February 8, 2023
Developing a mortality risk prediction model using data of 3663 hospitalized COVID-19 patients: a retrospective cohort study in an Egyptian University HospitalSahar Kandil, Ayman I Tharwat, Sherief M Mohsen, et al.
Dermatology and Therapy|January 15, 2026
Egyptian National Consensus on Dermocosmetic Ingredient Selection Across Common Dermatology Scenarios: A RAND/UCLA Appropriateness StudyMahmoud A Rageh, Wael M Seoudy, Mohamed F Abozeid, et al.
Clinical, Cosmetic and Investigational Dermatology|October 20, 2025
Consensus Recommendations for the Management of Androgenetic Alopecia in Egypt: A Modified Delphi StudySara M Mohy, Mohamed F Abozeid, Wael M Seoudy, et al.
The Lancet. Haematology|December 22, 2015
Safety and tolerability of eltrombopag versus placebo for treatment of thrombocytopenia in patients with advanced myelodysplastic syndromes or acute myeloid leukaemia: a multicentre, randomised, placebo-controlled, double-blind, phase 1/2 trialUwe Platzbecker, Raymond S M Wong, Amit Verma, et al.
Pageof 6